{"name":"Response Pharmaceuticals","slug":"response-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE0yTnF2SjhqN3VIMDhrQ2duMWg4VEJnSDhyQ21lTTZKQWNwUjNIS2JrZFY3ZS1weG0yYUhjMXpkWHI1cFR5S2pVY3N6NG9ta2lORXVmWFdpSVFqVUVuSDR4Qndsei00SFBCWnd4SUlSOFROUk9LYU1xeEdB?oc=5","date":"2026-03-19","type":"pipeline","source":"Pharmaceutical Executive","summary":"What Governance Resets Should Pharma Companies Take in Response to AI? - Pharmaceutical Executive","headline":"What Governance Resets Should Pharma Companies Take in Response to AI?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQcl9ZWVpWVUtaaWZxakhaLWJGQ3lGUWVSUDJiU01VYVVVcGpaOGdSbzk4dWk4SEFmNFRRUF8wQTNxM3FJQnhYNGI5TTZtYmQ2RkJPZUI4bi1YU0VNVmxtMzZiT2RZbmppZlNnNEFIdUFqTkVHc0lWYU5RQnRQd0Jpa1Zob3g1MW9uZndla3dqUTBoN29Lc0E?oc=5","date":"2026-03-13","type":"regulatory","source":"Fierce Pharma","summary":"FDA fires off another manufacturing-related CRL, this one to Hyloris - Fierce Pharma","headline":"FDA fires off another manufacturing-related CRL, this one to Hyloris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOR0dOSHZ1aTFLQV9odWRnak42NUVVZ2gtRzNPU29xb2w0bXZaTlNPb0lxajVYLUFnODJpN0w4VnZpR3FORmNMMnkyMFltR3VRMDM3LUd1bUpzUnpYTWtFX3VUUEhqc2EyR1p0WHlYMEJSSlQyZ0JKM1lJamNmWk14Q2ZkSmh6MWk1ZDlR?oc=5","date":"2026-02-04","type":"regulatory","source":"Yahoo Finance","summary":"Pharming Group (ENXTAM:PHARM) Valuation After FDA Complete Response Letter On Joenja Pediatric Filing - Yahoo Finance","headline":"Pharming Group (ENXTAM:PHARM) Valuation After FDA Complete Response Letter On Joenja Pediatric Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeE5uTEVELXM5QVdlaHRxalZqYjNFOFlKVmJ2MnVDaEJsOXpIVkNhb2RiMmdHX3pyWmVPQmFReU5CR2hJT0J4aDZZY0NSMXZlZnhaWl85Y2N0ZWxaWTlFRHBSMmtSSlVUdnlsVjJfLUR6UEh0N2dHWWNKU3JCR040Y1BkVlRiWWE2ZkdLLUVYTWN6WmtfdkN4dVd1dkhiSnhjYTUxT0pNa3hUUHc?oc=5","date":"2026-02-04","type":"regulatory","source":"Pharmaceutical Commerce","summary":"How AI Ecosystems Could Transform Pharma Demand and Crisis Response - Pharmaceutical Commerce","headline":"How AI Ecosystems Could Transform Pharma Demand and Crisis Response","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQSmxaVDB2N2ExWDgxWE5rbWtiYzM5M1pIbzBlZGNYYUN5ZzJCWl9XMldqQ0FwNjhMRXIwSmx4MDVmbUZmRjZ6aVVKckNiOXJXcWVlQVlfVEwtQXB3X2h2Qnc1UFUxUk5vZFZKdTJpbG9EbURZSHBRNXpGbS1DUWpJdXI4T1daaEFpT1VkV3gzaVVCWVNCQ01sTE56dlVnbThYNHZvbnpzM2F1U1owUUJNWkJfQ1JWV3B2Y1E?oc=5","date":"2026-01-20","type":"pipeline","source":"Stock Titan","summary":"Phio cancer drug clears tumors in 10 of 14, no dose-limiting toxicities - Stock Titan","headline":"Phio cancer drug clears tumors in 10 of 14, no dose-limiting toxicities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQeGJUMGNTTXpDcTlmU2tkZkxPajlSMnpXQlpWa21ZZy1YbGpLNGR3Nm1rRlNmZnNJcHo5dGdoYkcxc3NudlVBZjhVMEdyRElpdWt0YU1QVHR1QV83RkNKVWl1OWY5T25uUnEzNERsY1hxLW1BVUxSVHU1NEVmR3FpWEp2OHdxcnFpamdZY3ZIQnBCTC0wSWxDeldEalZPV19RcmhqR2J2MTNEQWVoZnI4?oc=5","date":"2026-01-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"JPM26: Fujifilm’s modular manufacturing answer to pharma tariffs - Pharmaceutical Technology","headline":"JPM26: Fujifilm’s modular manufacturing answer to pharma tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNEJzZWhQVERZdVowdWpRdG0zWjJUWjJZclM2OTNGM2I2clFNZHVnakN3Z1hfZ1N0T3JYTF80QWxhWEhyem1oRWx1aF92RFRUbHpRcnlfMzBRc21Zd181d01WZmJBOGNEMjlERnl1bWZYcUZKNWVuOFNlRVA3cXg1Yi1GZ1FZYm5HdHh3U2o0dnJaa2Nzb3k5RF9CUVllWlhEUE9Ybnk4RVpkZWFrMHhScWQ1RnhpbUdYSXZzbnJuVFJkQndmR1Npdk5ES0NzOU1kY3dj?oc=5","date":"2025-09-30","type":"pipeline","source":"Investing.com","summary":"Bernstein highlights pharma industry’s response to Trump drug pricing deadline - Investing.com","headline":"Bernstein highlights pharma industry’s response to Trump drug pricing deadline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbjRjVGFhLUZmakczN1F1aENtY3JSOFVKREg2dTB1YXJaYWtZcm5WaFBiZzMtOTlQMzkzWTdhLXBCOEJKNkpMM2VFRmdHS3pmZ201VTY1ODFkZGR5UUJjRmVPNVZWdU9OSk9fX21EU0FCbVJaeDZFZzEwS2x4MThTbTV6a1pBVzcwTTFwMnFvRlhqWDEzandhR3NtUWRaSVU4S0U0dUlBdkppdmJXM0VDNWhKZlQ4SDJHQTJMU29uNA?oc=5","date":"2025-08-20","type":"pipeline","source":"PharmTech.com","summary":"Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results - PharmTech.com","headline":"Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQUERKeUVZWGU5bVZISk9hbkxPMjRlbi03RnZ4eEgzX2hjb2JpajVHc0hWbU0tOHB0NTVydWRySl90QUVKR0F0eWdVTUVOYXlvZjktTG1qQ3BWR0FHQnZUSDcxOVg4LUI5OFpQOXRiLUpaQWJWTEVUaGZINHg2cTZSUm01SDUzalJ2TWFhdXhVbXBGWTJnVnVSbmowb2pxVnlaYk40TXJ3UTFYTW90cms5MDlCbE5aaWR5Z1VjQWV3?oc=5","date":"2025-08-14","type":"pipeline","source":"BioSpace","summary":"Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy - BioSpace","headline":"Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNb2RKQ28xaWd0SUdnWHh3bUIwLTRRWGRXeW5OV0lCQkkwV1lFV2Yxcmd4M0VCT1FHb2hKcWExM1ZaREt5d18wSXJKZmY0M051S3YyajFfUmlza1lHMl9BVVNKTEduaS1uSnIyODdvaFFKRGg5OUctX3BxZzVwOXJva0xMNWk1QjU3dGdjaDJtRUx4RW9jTTd3UDRVSTV4QjdvQ0lDQ0tCbU5EZw?oc=5","date":"2025-08-13","type":"pipeline","source":"MedCity News","summary":"Response Pharma’s Novel Pill for Weight Loss Shows Promise as Post-GLP-1 Maintenance Therapy - MedCity News","headline":"Response Pharma’s Novel Pill for Weight Loss Shows Promise as Post-GLP-1 Maintenance Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE43UnpPa3N0R25RblJxZjl1VUFDS1lOUDFtS0ZpVlIyeUxVaGRFdUhNd0NONzlrRUkzM1VOelM3ZC1WM29nODU5WjByamF4czlpNlBz?oc=5","date":"2025-08-13","type":"pipeline","source":"FirstWord Pharma","summary":"Response Pharma says RDX-002 limits weight regain post-GLP-1 - FirstWord Pharma","headline":"Response Pharma says RDX-002 limits weight regain post-GLP-1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQbF8zbDVUalRyb19zVnJOMmMxWVZWc1U3UEgtRWpWTHhUOTVzemwyQ3A3Ykw0dHlqTl92VWVRWkphZ3ZaUVEwVXd6RHIxSFZKbUw1ZDNRN0d6b2k2cl9xbmZ6UDVUTDAwcnJ2U0w1XzI4blhzMVlCQjRjX2RlVVE4V0J3bXUzRHhFOExDR1N2V09pWlZ0SU0tRGx0ckJWVDA1STh4QXJIQUdDazFMRFYzTHhObTNLQTQ?oc=5","date":"2025-07-11","type":"regulatory","source":"Pharmacy Times","summary":"FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade - Pharmacy Times","headline":"FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}